Wegovy is covered for the cardiovascular indication (CVD plus overweight or obesity) following the CMS coverage update in March 2024, not for weight loss alone
The additional GIP action affects insulin sensitivity and energy utilization, which can lead to greater weight-loss potential for some patients
It plays a pivotal role in maintaining the overall health of our cells and tissues by protecting them from the damaging effects of free radicals and oxidative stress
Actual rates of alopecia were low, ranging from roughly 3 to 9 per 1,000 people per year, with between 11,000 and 15,000 people in each drug-class group
Nat Rev Rheumatol
The bottom line Since the earliest days of GLP-1s with exenatide in 2005, through the past two decades to Ozempic and Mounjaro, the field has come a long way and will continue to evolve